EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth

Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines

(2011) Estefanía Carrasco-García et al.   EXPERIMENTAL CELL RESEARCH

Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non–small lung cancer with EGFR TKIs-resistant mutation

(2011) Feng Pan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines

(2010) Hua Cheng et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics

(2010) Camilla Krakstad et al.   Molecular Cancer

Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib

(2009) Marc-Eric Halatsch et al.   JOURNAL OF NEUROSURGERY

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

(2008) A. A. Brandes et al.   CLINICAL CANCER RESEARCH

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

(2008) Paul D. Brown et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

(2008) Michael D. Prados et al.   JOURNAL OF CLINICAL ONCOLOGY

Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status

(2008) Catia Cemeus et al.   JOURNAL OF NEURO-ONCOLOGY

Statins-Mediated Inhibition of Rho GTPases as a Potential Tool in Anti-Tumor Therapy

(2008) Chiara Riganti et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY